Related references
Note: Only part of the references are listed.Phytochemical-Mediated Glioma Targeted Treatment: Drug Resistance and Novel Delivery Systems
Hang Cao et al.
CURRENT MEDICINAL CHEMISTRY (2020)
Postoperative standard chemoradiotherapy benefits primary glioblastoma patients of all ages
Guanzhang Li et al.
CANCER MEDICINE (2020)
Pivotal Role of STAT3 in Shaping Glioblastoma Immune Microenvironment
Christina Piperi et al.
CELLS (2019)
MGMT: Immunohistochemical Detection in High-Grade Astrocytomas
Eric S. Lipp et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2019)
Momelotinib sensitizes glioblastoma cells to temozolomide by enhancement of autophagy via JAK2/STAT3 inhibition
Tie Liu et al.
ONCOLOGY REPORTS (2019)
Monitoring NAD(P)H by an ultrasensitive fluorescent probe to reveal reductive stress induced by natural antioxidants in HepG2 cells under hypoxia
Xiaohong Pan et al.
CHEMICAL SCIENCE (2019)
Current promising treatment strategy for glioblastoma multiform: A review
Sanjib Bahadur et al.
ONCOLOGY REVIEWS (2019)
Repurposing drugs for glioblastoma: From bench to bedside
Joao Basso et al.
CANCER LETTERS (2018)
Resveratrol Suppresses the Growth and Enhances Retinoic Acid Sensitivity of Anaplastic Thyroid Cancer Cells
Yi-Tian Li et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Effectiveness of temozolomide combined with whole brain radiotherapy for non-small cell lung cancer brain metastases
Ying Zhu et al.
THORACIC CANCER (2018)
Meta-analysis of whole-brain radiotherapy plus temozolomide compared with whole-brain radiotherapy for the treatment of brain metastases from non-small-cell lung cancer
Yong Xin et al.
CANCER MEDICINE (2018)
Microglia/Astrocytes-Glioblastoma Crosstalk: Crucial Molecular Mechanisms and Microenvironmental Factors
Diana Matias et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2018)
Reverse chemomodulatory effects of the SIRT1 activators resveratrol and SRT1720 in Ewing's sarcoma cells: resveratrol suppresses and SRT1720 enhances etoposide- and vincristine-induced anticancer activity
Juergen Sonnemann et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2016)
Resveratrol sensitizes glioblastoma-initiating cells to temozolomide by inducing cell apoptosis and promoting differentiation
Hao Li et al.
ONCOLOGY REPORTS (2016)
Lumbar puncture-administered resveratrol inhibits STAT3 activation, enhancing autophagy and apoptosis in orthotopic rat glioblastomas
Song Xue et al.
ONCOTARGET (2016)
Sulforaphane enhances temozolomide-induced apoptosis because of down-regulation of miR-21 via Wnt/-catenin signaling in glioblastoma
FengMing Lan et al.
JOURNAL OF NEUROCHEMISTRY (2015)
Diffusion Efficiency and Bioavailability of Resveratrol Administered to Rat Brain by Different Routes: Therapeutic Implications
Xiao-Hong Shu et al.
NEUROTHERAPEUTICS (2015)
CRABP-II- and FABP5-independent responsiveness of human glioblastoma cells to all-trans retinoic acid
Shi-Lin Xia et al.
ONCOTARGET (2015)
The Regenerating Spinal Cord of Gecko Maintains Unaltered Expression of β-Catenin Following Tail Amputation
Honghua Song et al.
JOURNAL OF MOLECULAR NEUROSCIENCE (2015)
Short-Term Resveratrol Exposure Causes In Vitro and In Vivo Growth Inhibition and Apoptosis of Bladder Cancer Cells
Mo-Li Wu et al.
PLOS ONE (2014)
Resveratrol abrogates the Temozolomide-induced G2 arrest leading to mitotic catastrophe and reinforces the Temozolomide-induced senescence in glioma cells
Eduardo C. Filippi-Chiela et al.
BMC CANCER (2013)
Perillyl Alcohol for the Treatment of Temozolomide-Resistant Gliomas
Hee-Yeon Cho et al.
MOLECULAR CANCER THERAPEUTICS (2012)
CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 20052009
Therese A. Dolecek et al.
NEURO-ONCOLOGY (2012)
O6-Methylguanine DNA methyltransferase expression in tumor cells predicts outcome of radiotherapy plus concomitant and adjuvant temozolomide therapy in patients with primary glioblastoma
Reiko Watanabe et al.
BRAIN TUMOR PATHOLOGY (2011)
Overcoming Temozolomide Resistance in Glioblastoma via Dual Inhibition of NAD+ Biosynthesis and Base Excision Repair
Eva M. Goellner et al.
CANCER RESEARCH (2011)
Phase I Study of Temozolomide and Laromustine (VNP40101M) in Patients With Relapsed or Refractory Leukemia
David Rizzieri et al.
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA (2010)
Gene expression profiling predicts response to temozolomide in malignant gliomas
Atsuo Yoshino et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2010)
Therapy for Recurrent High-Grade Gliomas: Does Continuous Dose-Intense Temozolomide Have a Role?
Patrick Y. Wen
JOURNAL OF CLINICAL ONCOLOGY (2010)
O-6-Methylguanine DNA methyltransferase protein expression in tumor cells predicts outcome of temozolomide therapy in glioblastoma patients
Sabine Spiegl-Kreinecker et al.
NEURO-ONCOLOGY (2010)
Temozolomide in malignant gliomas of childhood: A United Kingdom Children's Cancer Study Group and French Society for Pediatric Oncology Intergroup study
LS Lashford et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Share Paper
